Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 1
1(50.0%)
2Total
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06575855Not ApplicableCompleted

Comparative Effectivenes of IASTM and MET on Post Operative Elbow Stiffness

Role: collaborator

NCT04810117Completed

Monitoring the IgG/IgM Antibodies in COVID-19 Patients

Role: lead

NCT05389943Phase 1Unknown

The Effect of Vitamin D3 Therapy in Post Menopausal Women and Assessment of Changes in Bone Mineral Density After Orally Vitamin D3 Administration

Role: lead

NCT04432038Unknown

Healthy Lifestyle or Pro-health Obsession During the Pandemic

Role: collaborator

NCT04714515Completed

Montelukast - a Treatment Choice for COVID-19

Role: lead

All 5 trials loaded